This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

For healthcare professionals only

You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.

 

This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.

 

This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.

I hereby declare I am a non-US health care professional and that I have read and agreed to the terms mentioned above.

More Than Height

At Novo Nordisk, we are committed to raise awareness for growth disorders and educate the population on the importance of Growth through the growth calculator on MoreThanHeight. How growth calculator can support growth monitoring in children?
Patient perspectives

Get a firsthand insight from patients and their families about what it means to live with a growth disorder.

ENDO 2024 Banner

Continue exploring the products and initiatives showcased at the congress, even after the live days of ENDO are over. Keep learning here.

Norditropin®

We’re Aiming Higher to Meet Your Expectations.
About Sogroya®

Sogroya® is a once-weekly growth hormone therapy for your paediatric patients with growth hormone deficiency.1

1.

Sogroya® Summary of Product Characteristics. 2022:1-92.